Total Payments
$81,803
2024 Payments
$7,163
Companies
67
Transactions
1,892
Medicare Patients
4,664
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$46,770 (57.2%)
Other$29,520 (36.1%)
Consulting$4,343 (5.3%)
Travel$841.83 (1.0%)
Education$328.56 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $46,770 | 1,845 | 57.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,495 | 18 | 36.1% |
| Consulting Fee | $4,343 | 8 | 5.3% |
| Travel and Lodging | $841.83 | 10 | 1.0% |
| Education | $328.56 | 10 | 0.4% |
| Honoraria | $25.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31,078 | 219 | $0 (2024) |
| GlaxoSmithKline, LLC. | $8,842 | 368 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,117 | 229 | $0 (2024) |
| PFIZER INC. | $5,627 | 96 | $0 (2024) |
| GENZYME CORPORATION | $4,030 | 74 | $0 (2024) |
| Optinose US, Inc. | $3,077 | 24 | $0 (2023) |
| Grifols USA, LLC | $2,134 | 105 | $0 (2024) |
| BioCryst US Sales Co., LLC | $1,884 | 67 | $0 (2024) |
| ABBVIE INC. | $1,780 | 54 | $0 (2024) |
| Amgen Inc. | $1,722 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,163 | 214 | Cycle Pharmaceuticals Inc ($1,145) |
| 2023 | $7,648 | 244 | GlaxoSmithKline, LLC. ($1,632) |
| 2022 | $7,534 | 233 | GlaxoSmithKline, LLC. ($1,463) |
| 2021 | $8,968 | 238 | PFIZER INC. ($1,748) |
| 2020 | $11,236 | 230 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,150) |
| 2019 | $14,731 | 281 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,362) |
| 2018 | $16,329 | 253 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,562) |
| 2017 | $8,193 | 199 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,490) |
All Payment Transactions
1,892 individual payment records from CMS Open Payments — Page 1 of 76
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Analgesic | ||||||
| 12/19/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Analgesic | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Immunology | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Immunology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: PAIN | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation & Immunology | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.71 | General |
| Category: Immunology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Analgesic | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $115.99 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Immunology | ||||||
| 11/29/2024 | Cycle Pharmaceuticals Inc | SAJAZIR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,120.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 959 | 21,588 | $649,997 | $330,561 |
| 2022 | 23 | 1,078 | 22,047 | $664,196 | $353,593 |
| 2021 | 24 | 1,124 | 22,268 | $596,867 | $332,198 |
| 2020 | 27 | 1,503 | 22,134 | $603,535 | $316,498 |
Total Patients
4,664
Total Services
88,037
Medicare Billing
$1.3M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 90 | 11,570 | $185,120 | $142,030 | 76.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 890 | $133,500 | $70,826 | 53.1% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 12 | 1,981 | $118,860 | $58,296 | 49.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 99 | 1,257 | $62,850 | $14,157 | 22.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 25 | 1,559 | $28,062 | $6,068 | 21.6% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 14 | 957 | $19,140 | $4,839 | 25.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 62 | 93 | $6,975 | $4,796 | 68.8% |
| J0285 | Injection, amphotericin b, 50 mg | Office | 2023 | 19 | 138 | $6,900 | $3,891 | 56.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 298 | $14,900 | $3,816 | 25.6% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 21 | 498 | $9,960 | $3,710 | 37.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $12,600 | $3,414 | 27.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 62 | 93 | $13,950 | $3,366 | 24.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $4,500 | $2,083 | 46.3% |
| J3370 | Injection, vancomycin hcl, 500 mg | Office | 2023 | 51 | 984 | $9,840 | $1,776 | 18.0% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 32 | 53 | $4,505 | $1,773 | 39.4% |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | Office | 2023 | 45 | 856 | $8,560 | $1,608 | 18.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 22 | $1,760 | $1,105 | 62.8% |
| 92550 | Test for eardrum and muscle function | Office | 2023 | 32 | 53 | $1,325 | $1,039 | 78.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,400 | $1,000 | 71.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 51 | 73 | $1,825 | $613.20 | 33.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 13 | 14 | $840.00 | $232.96 | 27.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 105 | $2,625 | $121.75 | 4.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 104 | 12,003 | $192,048 | $144,398 | 75.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 758 | $113,700 | $60,316 | 53.0% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 11 | 1,832 | $109,920 | $54,867 | 49.9% |
About Dr. Robert Mittman, MD
Dr. Robert Mittman, MD is a Allergy & Immunology healthcare provider based in Bayside, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821166877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mittman, MD has received a total of $81,803 in payments from pharmaceutical and medical device companies, with $7,163 received in 2024. These payments were reported across 1,892 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($46,770).
As a Medicare-enrolled provider, Mittman has provided services to 4,664 Medicare beneficiaries, totaling 88,037 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Bayside, NY
- Active Since 11/30/2006
- Last Updated 01/12/2011
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821166877
Products in Payments
- SPIRIVA RESPIMAT (Drug) $11,772
- DUPIXENT (Biological) $4,994
- EUCRISA (Drug) $4,202
- NUCALA (Biological) $3,406
- Xhance (Drug) $3,077
- TRELEGY ELLIPTA (Drug) $2,750
- FARXIGA (Drug) $1,794
- BREZTRI (Drug) $1,689
- Prolastin-C Liquid (Biological) $1,613
- RAYOS (Drug) $1,580
- UBRELVY (Drug) $1,402
- ORLADEYO (Drug) $1,345
- STIOLTO RESPIMAT (Drug) $1,202
- SAJAZIR (Drug) $1,120
- SYMBICORT (Drug) $842.34
- OPZELURA (Drug) $818.99
- Repatha (Biological) $739.37
- Neo-Synalar (Drug) $700.00
- AIRSUPRA (Drug) $670.24
- BREO (Drug) $652.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.